14
Views
7
CrossRef citations to date
0
Altmetric
Original Article

High Dose Hydroxyurea in Collection of Philadelphia Chromosome-Negative Stem Cells in Chronic Myeloid Leukaemia

, , , &
Pages 73-78 | Received 13 Sep 1992, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

J. Mehta, R. Powles, S. Singhal, G. J. Swansbury, B. Millar, V. Shepherd, J. Bell, T. Min, S. Cabral & J. Treleaven. (1996) High-dose Hydroxyurea and G-CSF to Collect Philadelphia-Negative Cells in Chronic Myeloid Leukemia: Preliminary Results. Leukemia & Lymphoma 23:1-2, pages 107-111.
Read now

Articles from other publishers (5)

Nicolas Chatain, Steffen Koschmieder & Edgar Jost. (2020) Role of Inflammatory Factors during Disease Pathogenesis and Stem Cell Transplantation in Myeloproliferative Neoplasms. Cancers 12:8, pages 2250.
Crossref
Lisa Pleyer, Ulrich Germing, Wolfgang R. Sperr, Werner Linkesch, Sonja Burgstaller, Reinhard Stauder, Michael Girschikofsky, Martin Schreder, Michael Pfeilstocker, Alois Lang, Thamer Sliwa, Dietmar Geissler, Konstantin Schlick, Gudrun Placher-Sorko, Georg Theiler, Josef Thaler, Martina Mitrovic, Daniel Neureiter, Peter Valent & Richard Greil. (2014) Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival. Leukemia Research 38:4, pages 475-483.
Crossref
Tomoaki Fujisaki, Teruhisa Otsuka, Hisashi Gondo, Takashi Okamura, Yoshiyuki Niho, Akira Ohhinata & Fuminori Abe. (2003) Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia. International Immunopharmacology 3:6, pages 901-907.
Crossref
Stephen G. O'Brien. (1997) 12 Autografting for chronic myeloid leukaemia. Baillière's Clinical Haematology 10:2, pages 369-388.
Crossref
George Marcoullis, Jayesh Mehta & Jennie Treleaven. (1995) Autologous bone marrow and peripheral blood stem cell transplantation in haematological malignancies: current status. Medical Oncology 12:4, pages 209-218.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.